Cargando…
Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus causing coronavirus disease 2019 (COVID-19), has affected human lives across the globe. On 11 December 2020, the US FDA granted an emergency use authorization for the first COVID-19 vaccine, and vaccines are now wide...
Autores principales: | Hajra, Adrija, Gupta, Manasvi, Ghosh, Binita, Ashish, Kumar, Patel, Neelkumar, Manek, Gaurav, Rai, Devesh, Sreenivasan, Jayakumar, Goel, Akshay, Lavie, Carl J., Bandyopadhyay, Dhrubajyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612108/ https://www.ncbi.nlm.nih.gov/pubmed/34817850 http://dx.doi.org/10.1007/s40256-021-00511-8 |
Ejemplares similares
-
Correction to: Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis
por: Hajra, Adrija, et al.
Publicado: (2021) -
COVID-19 Pandemic: Cardiovascular Complications and Future Implications
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2020) -
In-hospital clinical outcomes of transcatheter aortic valve replacement in patients with concomitant carotid artery stenosis: Insights from the national inpatient sample
por: Chakraborty, Sandipan, et al.
Publicado: (2020) -
Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis
por: Hajra, Adrija, et al.
Publicado: (2023) -
Screening for diabetic retinopathy: New methods to come
por: Hajra, Adrija, et al.
Publicado: (2016)